← Leaderboards
Craig Gelfand
Advent Therapeutics, Inc.
$2,774,847
Attributed
$5,549,693
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,549,693 · 2
By mechanism
R44$5,324,693 · 1
R43$225,000 · 1
Top collaborators
- Virender K Rehan6 shared
Others in their field
Other Emerging Leaders on “Injections”
- Yunda Huang · Fred Hutchinson Cancer Center$58,397,458
- Xinhua Li · Nano Terra, Inc.$35,520,438
- Laura McNay · Leidos Biomedical Research, Inc.$15,147,252
- Manish Ishwar Shah · Baylor College Of Medicine$13,280,421
- Benjamin E Deverman · Broad Institute, Inc.$12,739,936
- Nikej Shah · Nirsum Laboratories, Inc.$12,506,430
Research focus
InjectionsIntramuscularHyperoxiaInhalationInnovationInterestDrug DevelopmentFda ApprovedEnteralEffectivenessAerosolsCollaborationsAll-Trans-RetinolFormulationCostConfidential InformationDrug Delivery SystemsDoseBiological MarkersAnimal ModelBiotechnologyAerosolizedBronchopulmonary DysplasiaIntramuscular Injections
Grant awards (6)
Aerosolized Vitamin A: Developing a Prevention for Hyperoxic Lung Injury and Bronchopulmonary Dysplasia, with Focus on Neonatal Lung Maturation$993,128
R44 · FY2025 · HL · contact PI
Aerosolized Vitamin A: Developing a Prevention for Hyperoxic Lung Injury and Bronchopulmonary Dysplasia, with Focus on Neonatal Lung Maturation$993,934
R44 · FY2024 · HL · contact PI
Aerosolized Vitamin A: Developing a Prevention for Hyperoxic Lung Injury and Bronchopulmonary Dysplasia, with Focus on Neonatal Lung Maturation$995,121
R44 · FY2023 · HL · contact PI
Aerosolized Vitamin A: Impact on Neonatal Lung Maturation, Hyperoxic Lung Injury and Bronchopulmonary Dysplasia$1,270,686
R44 · FY2021 · HL · contact PI
Aerosolized Vitamin A: Impact on Neonatal Lung Maturation, Hyperoxic Lung Injury and Bronchopulmonary Dysplasia$1,071,824
R44 · FY2020 · HL · contact PI
Aerosolized vitamin A impact on lung maturation and hyperoxic neonatal lung injury$225,000
R43 · FY2018 · HL · contact PI